The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.


Journal

Toxicology
ISSN: 1879-3185
Titre abrégé: Toxicology
Pays: Ireland
ID NLM: 0361055

Informations de publication

Date de publication:
10 2021
Historique:
received: 05 02 2021
revised: 24 08 2021
accepted: 26 08 2021
pubmed: 1 9 2021
medline: 28 12 2021
entrez: 31 8 2021
Statut: ppublish

Résumé

Per- and polyfluoroalkyl substances (PFAS) are a family of chemicals that are ubiquitous in the environment. Some of these chemicals, such as perfluorooctanesulfonic acid (PFOS), perfluorohexanesulfonate (PFHxS) and perfluorooctanoic acid (PFOA), are found in human sera and have been shown to cause liver steatosis and reduce postnatal survival and growth in rodents. The purpose of this work is to evaluate the impact of diet and PFAS exposure to mouse dam (mus musculus) on the risk to pup liver and metabolism endpoints later in life, as well as evaluate PFAS partitioning to pups. Timed-pregnant dams were fed a standard chow diet or 60 % kcal high fat diet (HFD). Dams were administered either vehicle, 1 mg/kg PFOA, 1 mg/kg PFOS, 1 mg/kg PFHxS, or a PFAS mixture (1 mg/kg of each PFOA, PFOS, and PFHxS) daily via oral gavage from gestation day 1 until postnatal day (PND) 20. At PND 21, livers of dams and 2 pups of each sex were evaluated for lipid changes while remaining pups were weaned to the same diet as the dam for an additional 10 weeks. Dam and pup serum at PND 21 and PND 90 were also evaluated for PFAS concentration, alanine aminotransferase (ALT), leptin and adiponectin, and glycosylated hemoglobin A1c. Perinatal exposure to a HFD, as expected, increased pup body weight, maternal liver weight, pup liver triglycerides, pup serum ALT, and pup serum leptin. PFOA and the PFAS mixture increased liver weights, and. treatment with all three compounds increased liver triglycerides. The maternal HFD increased dam and pup serum PFAS levels, however, was protective against PFOA-induced increase in serum ALT and observed increases in liver triglycerides. The PFAS mixture had very distinct effects when compared to single compound treatment, suggesting some cumulative effects, particularly when evaluating PFAS transfer from dam to pup. This data highlights the importance of diet and mixtures when evaluating liver effect of PFAS and PFAS partitioning.

Identifiants

pubmed: 34464680
pii: S0300-483X(21)00244-4
doi: 10.1016/j.tox.2021.152921
pmc: PMC8554779
mid: NIHMS1736781
pii:
doi:

Substances chimiques

Alkanesulfonic Acids 0
Caprylates 0
Environmental Pollutants 0
Fluorocarbons 0
Sulfonic Acids 0
perfluorohexanesulfonic acid 355-46-4
perfluorooctanoic acid 947VD76D3L
perfluorooctane sulfonic acid 9H2MAI21CL

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

152921

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM103430
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES027706
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Reprod Toxicol. 2009 Jun;27(3-4):239-245
pubmed: 19429402
Sci Total Environ. 2018 Sep 15;636:1058-1069
pubmed: 29913568
Toxicology. 2014 Feb 28;316:43-54
pubmed: 24374136
Toxicology. 2019 Mar 15;416:1-14
pubmed: 30711707
Toxicol Pathol. 2015 Jun;43(4):558-68
pubmed: 25398757
Biochim Biophys Acta. 2012 Jul;1820(7):1092-101
pubmed: 22484034
Toxicol Sci. 2017 Mar 1;156(1):84-95
pubmed: 28013215
Environ Health Perspect. 2017 Jul 26;125(7):077018
pubmed: 28749778
Reprod Toxicol. 2012 Jul;33(4):428-440
pubmed: 21889587
Chem Res Toxicol. 2012 Jan 13;25(1):35-46
pubmed: 21985250
Environ Res. 2015 Jan;136:8-14
pubmed: 25460614
Environ Health Perspect. 2012 May;120(5):655-60
pubmed: 22289616
Diabetes Res Clin Pract. 2004 Feb;63(2):135-42
pubmed: 14739054
Toxicol Appl Pharmacol. 2020 Dec 1;408:115250
pubmed: 32979393
Toxicol Sci. 2003 Aug;74(2):369-81
pubmed: 12773773
Environ Pollut. 2020 Aug;263(Pt B):114182
pubmed: 32247900
Toxicol Sci. 2008 Nov;106(1):37-45
pubmed: 18703564
J Physiol. 2019 Jul;597(13):3333-3347
pubmed: 31115053
Can J Biochem Physiol. 1959 Aug;37(8):911-7
pubmed: 13671378
Environ Health Perspect. 2013 Nov-Dec;121(11-12):1313-8
pubmed: 24007715
Toxicology. 2005 Nov 5;215(1-2):149-69
pubmed: 16129535
Reprod Toxicol. 2012 Jul;33(4):441-451
pubmed: 21856411
Environ Sci Technol. 2010 Sep 15;44(18):7123-9
pubmed: 20722423
Int J Toxicol. 2018 Sep/Oct;37(5):383-392
pubmed: 30134762
Toxicology. 2008 Sep 29;251(1-3):8-20
pubmed: 18692542
Environ Sci Pollut Res Int. 2013 Nov;20(11):7970-8
pubmed: 23436123
Reprod Toxicol. 2009 Jun;27(3-4):258-265
pubmed: 18595657
Nutr Diabetes. 2017 Jan 16;7(1):e242
pubmed: 28092346
Toxicol Sci. 2011 Sep;123(1):290-303
pubmed: 21705711
Environ Sci Technol. 2017 Mar 7;51(5):2508-2518
pubmed: 28224793
Environ Health Perspect. 2007 Sep;115(9):1298-305
pubmed: 17805419
Int Immunopharmacol. 2010 Nov;10(11):1420-7
pubmed: 20816993
Toxicol Sci. 2021 Jul 16;182(1):82-95
pubmed: 33844015
Environ Sci Process Impacts. 2020 Dec 1;22(12):2345-2373
pubmed: 33125022
Environ Int. 2019 Aug;129:343-353
pubmed: 31150976
Toxicol Sci. 2007 Jan;95(1):108-17
pubmed: 17047030
Regul Toxicol Pharmacol. 2019 Aug;106:239-250
pubmed: 31078680
Am J Obstet Gynecol. 2010 Nov;203(5):495.e1-8
pubmed: 20822767
Toxicol Sci. 2017 Apr 1;156(2):387-401
pubmed: 28115654
PLoS One. 2014 Jan 31;9(1):e87137
pubmed: 24498028
PLoS One. 2014 Mar 24;9(3):e92805
pubmed: 24664181
Toxicol Sci. 2002 Jul;68(1):249-64
pubmed: 12075127
J Clin Endocrinol Metab. 2002 Apr;87(4):1856-63
pubmed: 11932330
Environ Sci Technol. 2001 Feb 15;35(4):766-70
pubmed: 11349290
Toxicol Sci. 2003 Aug;74(2):382-92
pubmed: 12773772
Environ Sci Technol. 2008 Apr 15;42(8):3096-101
pubmed: 18497172
Environ Pollut. 2019 Apr;247:1055-1063
pubmed: 30823334
Mol Cell Endocrinol. 2009 May 25;304(1-2):97-105
pubmed: 19433254
Toxicol Sci. 2002 Sep;69(1):244-57
pubmed: 12215680
Int Arch Occup Environ Health. 2007 Jul;80(7):643-8
pubmed: 17219182
Environ Health Perspect. 2011 Aug;119(8):1070-6
pubmed: 21501981
PLoS One. 2013;8(2):e57847
pubmed: 23469086
Occup Environ Med. 2018 Jan;75(1):46-51
pubmed: 29133598
Chemosphere. 2019 Oct;233:25-33
pubmed: 31163305
Toxicology. 2004 Mar 1;196(1-2):95-116
pubmed: 15036760
Arch Toxicol. 2008 Apr;82(4):239-46
pubmed: 17874065
Environ Res. 2017 Jul;156:175-182
pubmed: 28349882
Am J Gastroenterol. 2010 Jun;105(6):1354-63
pubmed: 20010922
Chemosphere. 2011 May;83(8):1035-44
pubmed: 21354591
Toxicol Sci. 2015 Aug;146(2):363-73
pubmed: 26001962
Sci Rep. 2015 May 14;5:10222
pubmed: 25974206
Toxicol Sci. 2011 Jul;122(1):134-45
pubmed: 21482639
Pediatr Res. 2018 Dec;84(6):854-860
pubmed: 30250302
Nutrients. 2019 Oct 05;11(10):
pubmed: 31590349
J Appl Toxicol. 2018 Feb;38(2):219-226
pubmed: 28857218
Toxicol Sci. 2006 Apr;90(2):510-8
pubmed: 16415327
Environ Sci Technol. 2018 Jun 19;52(12):7101-7110
pubmed: 29758986
J Immunotoxicol. 2017 Dec;14(1):188-195
pubmed: 28805477
Toxicology. 2003 Feb 1;183(1-3):117-31
pubmed: 12504346
Toxicol Lett. 2009 Oct 28;190(2):163-71
pubmed: 19616083
Toxicol Sci. 2020 Dec 1;178(2):311-324
pubmed: 32991729
Toxicology. 2008 Mar 20;245(3):194-205
pubmed: 18291570
Toxicol Sci. 2021 Apr 12;180(2):277-294
pubmed: 33483757
Environ Health Perspect. 2013 Mar;121(3):318-23
pubmed: 23308854
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5338-5348
pubmed: 31216000
Environ Sci Technol. 2011 Oct 1;45(19):8037-45
pubmed: 21469664
Toxicology. 2011 Oct 9;288(1-3):8-17
pubmed: 21723365
Endocrinology. 2018 Apr 1;159(4):1718-1733
pubmed: 29438518
Environ Health Perspect. 2016 Aug;124(8):1227-33
pubmed: 26978841
Am J Epidemiol. 2009 Oct 1;170(7):837-46
pubmed: 19692329
Environ Pollut. 2019 Nov;254(Pt B):113061
pubmed: 31454574
Reprod Toxicol. 2009 Jun;27(3-4):365-372
pubmed: 19429407
Mol Pharmacol. 1998 Jan;53(1):14-22
pubmed: 9443928
Front Physiol. 2018 May 29;9:645
pubmed: 29896121
J Expo Sci Environ Epidemiol. 2019 Mar;29(2):131-147
pubmed: 30470793
Reprod Toxicol. 2018 Jun;78:150-168
pubmed: 29694846
Toxicol Sci. 2007 Oct;99(2):366-94
pubmed: 17519394

Auteurs

Emily S Marques (ES)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.

Juliana Agudelo (J)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.

Emily M Kaye (EM)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.

Seyed Mohamad Sadegh Modaresi (SMS)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.

Marisa Pfohl (M)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.

Jitka Bečanová (J)

Graduate School of Oceanography, University of Rhode Island, 215 S Ferry Rd, Narragansett, RI 02882, USA.

Wei Wei (W)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA.

Marianne Polunas (M)

Rutgers Translational Sciences, Rutgers University, 33 Knightsbridge Road, Piscataway, NJ 08854, USA.

Michael Goedken (M)

Rutgers Translational Sciences, Rutgers University, 33 Knightsbridge Road, Piscataway, NJ 08854, USA.

Angela L Slitt (AL)

Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, 7 Greenhouse Rd, Kingston, RI 02881, USA. Electronic address: aslitt@uri.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH